drugset / Trial / NCT06964061

Evaluate Efficacy, Safety, Tolerability and Biodegradation of PA5346 Ocular Implant in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT06964061 ↗

Phase 1 Active not recruiting 12 enrolled PolyActiva Pty Ltd
NaSingle-groupOpen-labelTreatment

Summary

The goal of this clinical study is to learn how effective and safe is a single administration of PA5346 Ocular Implant for the reduction of intraocular pressure in adult patients with open-angle glaucoma or ocular hypertension. It will also assess how long it takes for PA5346 Ocular Implant to dissolve in the eye.

Timeline

Start
2025-06-10
Primary completion
2027-02-15
Completion
2027-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject PA5436 Ocular Implant Unknown 115 ug Other